THE RIGHT SIDE
Disruption and innovation are accelerating. We help you harness the power of change.
THE RIGHT SIDE
Disruption and innovation are
accelerating. We help you harness
the power of change.
COVID-19 has unleashed disruptive forces at a pace and magnitude unlike ever before, with trends such as digitization, medical advances and sustainability growing from ripples into tidal waves.
At Janus Henderson, we take the long view: Which of today’s trends are likely to endure? Which companies can build or defend competitive advantages? What new challenges need to be solved? As disruption continues, these questions can help identify not just growth, but durable growth, and guide us in our goal of delivering strong risk-adjusted returns in a highly disruptive world.
say COVID-19 accelerated their company’s digital transformation
|228||novel drug approvals|
from 2016 to 2020, up 105% from a decade ago
Internet of Things
expected by 2025, approximately 4 devices per person globally
spending on cloud services expected by 2022, up 49% from 2019
drop in global oil demand forecast by 2035, due to remote work and reduced air travel
AI & Machine Learning
potential contribution to the global economy by 2030
Source: “Covid-19 Digital Engagement Report,” Twilio, data as of August 2020; Gartner, data as of 17 November 2020; “Global Energy Perspective 2021,” McKinsey, data as of 12 January 2021; U.S. Food and Drug Administration, data as of 31 December 2021; IoT Analytics, data as of 19 November 2020 and PwC, data as of 2017.
Hear from our investment experts as they discuss how they are thinking about today’s evolving economy. Then learn how that thinking is translated into strategies that can help you stay on the right side of disruption.
We aim to identify not just growth, but durable growth in today’s disruptive economy.
Harness the Power of Disruption in Your Portfolio
Our strategies aim to identify long-term growth opportunities amid today’s accelerating disruption, backed by decades of investment experience, in-depth research capabilities and a disciplined approach that seeks to capitalize on disruptive trends while minimizing volatility.
Health Care Expertise
A team of analysts – many with science-based Ph.Ds – with decades of experience investing in the complex and dynamic health care sector.
Diversified across market cap, geography and subsector: biotechnology, pharmaceuticals, health care services and medical devices.
Integrated Risk Management
“Value at risk” framework aims to mitigate the volatility of drug development by limiting the position size of high-risk stocks.